388 related articles for article (PubMed ID: 23800635)
1. Nonadherence with INR monitoring and anticoagulant complications.
Witt DM; Delate T; Clark NP; Garcia DA; Hylek EM; Ageno W; Dentali F; Crowther MA
Thromb Res; 2013 Aug; 132(2):e124-30. PubMed ID: 23800635
[TBL] [Abstract][Full Text] [Related]
2. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
[TBL] [Abstract][Full Text] [Related]
4. Patient Specific Factors Influencing Adherence to INR Monitoring.
Kauffman YS; Schroeder AE; Witt DM
Pharmacotherapy; 2015 Aug; 35(8):740-7. PubMed ID: 26289306
[TBL] [Abstract][Full Text] [Related]
5. Evaluating warfarin management by pharmacists in a community teaching hospital.
Chilipko AA; Norwood DK
Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
[TBL] [Abstract][Full Text] [Related]
6. Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.
Witt DM; Delate T; Hylek EM; Clark NP; Crowther MA; Dentali F; Ageno W; Martinez KD; Garcia DA
Thromb Res; 2013; 132(6):770-5. PubMed ID: 24521790
[TBL] [Abstract][Full Text] [Related]
7. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
[TBL] [Abstract][Full Text] [Related]
8. Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients.
Barta AL; Nutescu EA; Thompson PA; Bussey HI; Gulseth MP
Am J Health Syst Pharm; 2015 Jul; 72(14):1188-94. PubMed ID: 26150568
[TBL] [Abstract][Full Text] [Related]
9. Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range.
Razouki Z; Ozonoff A; Zhao S; Jasuja GK; Rose AJ
Circ Cardiovasc Qual Outcomes; 2014 Sep; 7(5):664-9. PubMed ID: 25185245
[TBL] [Abstract][Full Text] [Related]
10. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
11. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
[TBL] [Abstract][Full Text] [Related]
12. Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.
Anthony CJ; Karim S; Ackroyd-Stolarz S; Fry A; Murphy NG; Christie R; Zed PJ
Ann Pharmacother; 2011 Jul; 45(7-8):881-7. PubMed ID: 21750309
[TBL] [Abstract][Full Text] [Related]
13. Real-World Impact of Setting a Narrow International Normalized Ratio Target Range in the Management of Older Adult Patients on Warfarin.
Ong PY; Koomanan N; Cheen MH; Lai YF; Lim SH; Kong MC; Ng HJ
Clin Appl Thromb Hemost; 2016 Sep; 22(6):528-34. PubMed ID: 26239317
[TBL] [Abstract][Full Text] [Related]
14. A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism.
Amiwero C; Campbell IA; Prescott RJ
Afr Health Sci; 2009 Sep; 9(3):179-85. PubMed ID: 20589148
[TBL] [Abstract][Full Text] [Related]
15. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
Sandén P; Renlund H; Svensson PJ; Själander A
Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
[TBL] [Abstract][Full Text] [Related]
16. Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.
Witt DM; Sadler MA; Shanahan RL; Mazzoli G; Tillman DJ
Chest; 2005 May; 127(5):1515-22. PubMed ID: 15888822
[TBL] [Abstract][Full Text] [Related]
17. Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis.
Grzymala-Lubanski B; Svensson PJ; Renlund H; Jeppsson A; Själander A
Heart; 2017 Feb; 103(3):198-203. PubMed ID: 27590664
[TBL] [Abstract][Full Text] [Related]
18. Pharmacy Technician Management of Stable, In-Range INRs Within a Clinical Pharmacy Anticoagulation Service.
Hawkins KL; King J; Delate T; Martinez K; McCool K; Clark NP
J Manag Care Spec Pharm; 2018 Nov; 24(11):1130-1137. PubMed ID: 30362923
[TBL] [Abstract][Full Text] [Related]
19. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
Larson BJ; Zumberg MS; Kitchens CS
Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
[TBL] [Abstract][Full Text] [Related]
20. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
